Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of GSK2321138A (FLU D-QIV) in Children
NCT01439360Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2011
- Primary completion
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 13
01
Overview
A Phase 3 trial of Influsplit in influenza, sponsored by GSK. Started Oct 2011; status: completed.
02
Drugs
Influsplit
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01439360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439360.